| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| -2.48% | +8.34% | +53.87% | +155.75% | 1,097B | |
| -1.76% | +6.23% | +66.27% | +53.44% | 622B | |
| -1.05% | +7.19% | +35.57% | +86.77% | 449B | |
| +0.83% | +4.18% | +31.11% | +23.88% | 334B | |
| -1.38% | +3.75% | +39.33% | +25.04% | 294B | |
| +0.30% | +2.56% | +31.62% | +40.64% | 286B | |
| -0.10% | +2.23% | -28.43% | -42.77% | 213B | |
| +0.44% | +4.35% | +29.69% | +63.10% | 195B | |
| +0.01% | +1.03% | +13.95% | +63.93% | 157B | |
| Average | -0.49% | +5.61% | +30.33% | +52.20% | 405.19B | |
| Weighted average by Cap. | -1.12% | +7.04% | +40.91% | +77.66% |
Employees
4
Sector
Pharmaceuticals
